Hans Geiselhöringer Appointed President of Nobel Biocare

Zurich, Switzerland As of January 1, Hans Geiselhöringer has taken over as President of Nobel Biocare. The appointment was made to strengthen the organisation around its strategic goals.

Since 2011, Mr. Geiselhöringer has served as Executive Vice President of Global Research, Products and Development, shaping a highly competitive product and innovation pipeline. Prior to that, he was Executive Vice President Global Marketing and Products from 2010 to 2011 and Head of NobelProcera and Guided Surgery from 2009 to 2010. He joined Nobel Biocare as Head of NobelProcera in 2008 and was appointed a member of the executive committee in 2009.

From 2004 to 2009, he acted as a Global Speaker for Nobel Biocare and with this appointment, he becomes the first Nobel Biocare customer and dental expert in the company’s history to take the reigns as its highest ranking executive.

In 1998, he founded DentalX GmbH, a leading dental laboratory chain specialising in implantology, anaplastology, functional and aesthetic reconstructions and imaging technologies. He is a trained dental technician and possesses great technical knowledge of the implant and CAD/CAM industries, as well as deep customer understanding and insights, enabling continuity of innovation at Nobel Biocare.

As a renowned expert on dental technologies and materials, he has published/co-published various clinical and research articles. He is also a member of numerous international dental associations and a recognised lecturer at dental conventions throughout the world.

Hans Geiselhöringer, President, Nobel Biocare, said: “Our focus on the patient remains steadfast and constant. Everything we do will continue to be patient-centred, clinically relevant and evidence-based. To strengthen our leadership in implant-based dentistry, we strongly focus on providing integrated digital solutions to improve the customer experience and increase productivity on all levels while ensuring a high level of clinical success and predictability. With our counterparts at KaVo Kerr Group, we have all the pieces in place today and we are grouping our highly skilled global teams together to form the industry’s new digital dentistry powerhouse. In summary, we at Nobel Biocare will continue our strong commitment to innovation, providing an ongoing pipeline of superior solutions that helps more customers treat more patients better.”